Effect of sacubitril/valsartan on renal function: a systematic review and meta‐analysis of randomized controlled trials
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of sacubitril/valsartan on renal function: a systematic review and meta‐analysis of randomized controlled trials
Authors
Keywords
-
Journal
ESC Heart Failure
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-09-22
DOI
10.1002/ehf2.13002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2020) Boris Bikbov et al. LANCET
- Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation: The PRIME Study
- (2019) Duk-Hyun Kang et al. CIRCULATION
- PCSK9 is Expressed in Human Visceral Adipose Tissue and Regulated by Insulin and Cardiac Natriuretic Peptides
- (2019) Marica Bordicchia et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays
- (2019) Nasrien E. Ibrahim et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
- (2019) Janani Rangaswami et al. CIRCULATION
- The combination of a neprilysin inhibitor (sacubitril) and angiotensin-II receptor blocker (valsartan) attenuates glomerular and tubular injury in the Zucker Obese rat
- (2019) Javad Habibi et al. Cardiovascular Diabetology
- Renal effects of Sacubitril/Valsartan in heart failure with reduced ejection fraction: a real life 1-year follow-up study
- (2019) Francesco Spannella et al. Internal and Emergency Medicine
- Efficacy and safety of combined neprilysin and RAS inhibition in heart failure: A meta-analysis of randomized controlled trials
- (2019) Qiang Geng et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Natriuretic Peptides in Heart Failure with Preserved Left Ventricular Ejection Fraction: From Molecular Evidences to Clinical Implications
- (2019) Daniela Maria Tanase et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- BNP as a Major Player in the Heart-Kidney Connection
- (2019) Ryuji Okamoto et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The therapeutic impact of entresto on protecting against cardiorenal syndrome-associated renal damage in rats on high protein diet
- (2019) Chih-Chao Yang et al. BIOMEDICINE & PHARMACOTHERAPY
- Effect of Sacubitril-Valsartan vs Enalapril on Aortic Stiffness in Patients With Heart Failure and Reduced Ejection Fraction
- (2019) Akshay S. Desai et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
- (2019) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure
- (2019) Scott D. Solomon et al. CIRCULATION
- The Impact of Sacrubitril/Valsartan on Clinical Treatment and hs-cTnT and NT-ProBNP Serum Levels and the Left Ventricular Function in Patients with Chronic Heart Failure
- (2019) Yang Gao et al. International Heart Journal
- Association Between Cardiac Natriuretic Peptides and Lipid Profile: a Systematic Review and Meta-Analysis
- (2019) Francesco Spannella et al. Scientific Reports
- Effects of Sacubitril/Valsartan Versus Irbesartan in Patients with Chronic Kidney Disease: A Randomised Double-Blind Trial
- (2018) Richard Haynes et al. CIRCULATION
- Particulate Guanylyl Cyclase A/cGMP Signaling Pathway in the Kidney: Physiologic and Therapeutic Indications
- (2018) Yang Chen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double-blind, 8-week study
- (2018) Deanna G. Cheung et al. Journal of Clinical Hypertension
- Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial
- (2018) Milton Packer et al. Lancet Diabetes & Endocrinology
- Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure
- (2018) Kevin Damman et al. JACC-Heart Failure
- Exploiting the Natriuretic Peptide Pathway to Preserve Glomerular Filtration in Heart Failure ∗
- (2018) Wilfried Mullens et al. JACC-Heart Failure
- Neprilysin Inhibition and Effects on Kidney Function and Surrogates of Cardiovascular Risk in Chronic Kidney Disease
- (2018) Matthew James et al. CIRCULATION
- Angiotensin–Neprilysin Inhibition in Acute Decompensated Heart Failure
- (2018) Eric J. Velazquez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Sacubitril/Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic HypertensionNovelty and Significance
- (2017) Bryan Williams et al. HYPERTENSION
- Biochemistry, Therapeutics, and Biomarker Implications of Neprilysin in Cardiorenal Disease
- (2016) Yang Chen et al. CLINICAL CHEMISTRY
- Blood pressure-independent renoprotection in diabetic rats treated with AT1 receptor-neprilysin inhibition compared with AT1 receptor blockade alone
- (2016) L. C. W. Roksnoer et al. CLINICAL SCIENCE
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
- (2016) Nathan R. Hill et al. PLoS One
- Combined neprilysin and RAS inhibition for the failing heart: straining the kidney to help the heart?
- (2015) Piero Ruggenenti et al. EUROPEAN JOURNAL OF HEART FAILURE
- Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction
- (2015) Adriaan A. Voors et al. EUROPEAN JOURNAL OF HEART FAILURE
- Neprilysin inhibition in chronic kidney disease
- (2014) P. Judge et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis
- (2013) K. Damman et al. EUROPEAN HEART JOURNAL
- The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial
- (2012) Scott D Solomon et al. LANCET
- Worsening kidney function in decompensated heart failure: treat the heart, don't mind the kidney
- (2011) P. Ruggenenti et al. EUROPEAN HEART JOURNAL
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Natriuretic Peptides: An Update on Bioactivity, Potential Therapeutic Use, and Implication in Cardiovascular Diseases
- (2008) S. Rubattu et al. AMERICAN JOURNAL OF HYPERTENSION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search